CCL2 and breast cancer: We have previously shown that T lymphocytes from mammary tumor-bearing mice produce CCL2 and that T cell-derived CCL2 could also contribute to tumor growth directly via its pro-angiogenic activity and indirectly by attracting monocytes that secrete growth-promoting factors (Owen et al., 2005).